TokenPost·
Bristol Myers Squibb and Erasca Arrange Evaluation of Cancer Drug Pair

Erasca will supply ERAS-0015 for the evaluation, which focuses on pancreatic ductal adenocarcinoma.
Every crypto headline. One feed. Updated every minute.

Erasca will supply ERAS-0015 for the evaluation, which focuses on pancreatic ductal adenocarcinoma.